We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
On an almost party-line vote of 230-192, the Democrats’ drug pricing bill H.R. 3 made its way out of the House on Thursday with an amendment requiring drugmakers to disclose drug prices in their direct-to-consumer advertising. Read More
The Senate confirmed Stephen Hahn yesterday in a 72-18 vote as the 24th FDA commissioner, taking over for acting FDA Commissioner Brett Giroir. Read More
Two dozen states are urging Purdue Pharma to consider specific actions to protect OxyContin patients, including discontinuing the 80 mg OxyContin dose. Read More
“This unproven treatment could cause patients to forgo or delay FDA-approved treatments for opioid addiction and withdrawal,” the agency said. Read More
Focusing on a new GAO report, a House subcommittee pressed CDER Director Janet Woodcock yesterday on “persistent challenges” facing the FDA’s foreign inspections, which include understaffing, unreliable translations and giving advance notice of inspections. Read More